返回 Agendas
Session 10: Workshop H - Industry and Stakeholders’ closed panel discussion; Room BC12
Session Chair(s)
Vincent I. Ahonkhai, MD, FAAFP
Senior Advisor, Global Health
Bill & Melinda Gates Foundation, United States
Oumkaltoum Lahlou
Head of Regulatory Affairs North & West Africa
Merck, Tunisia
Mercè Caturla Goñi
Global Access Regulatory Leader, Regulatory Policy (Africa and WHO)
Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium
William Mwatu
Chairman
Kenya Association of the Pharmaceutical Industry (KAPI), Kenya
Chair: Vincent I. Ahonkhai
Moderator: Oumkaltoum Lahlou
Co-Moderator: Merce Caturla
Rapporteur: William Mwatu
This session is set up as a panel discussion with industry representatives only. Main discussion points, comments and recommendations from this session as recorded by a rapporteur will be shared during next plenary session. Industry’s views of needs and opportunities for improvement related to the discussion points will be brought into perspective during the session.
注册方法
Registration fee includes conference delegate material, refreshments and lunches.
Registration fee can be settled via bank transfer or by Visa and MasterCard credit cards.